Assignee
MERZ PHARMA GMBH & CO KGAA
DE·82 granted patents·87 pending applications·359 citations·filing 2000–2025
Top patents by PatentIndex Score
169 records- 0196US10105421B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Oct 23, 2018·19 cites·17 claims
- 0295US8372645B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2010·Granted Feb 12, 2013·24 cites·7 claims
- 0395US7879341B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Feb 1, 2011·34 cites·22 claims
- 0494US9220783B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Dec 29, 2015·14 cites·6 claims
- 0592US10549042B2Botulinum toxin prefilled glass syringeMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Feb 4, 2020·13 cites·16 claims
- 0692US9827298B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted Nov 28, 2017·10 cites·4 claims
- 0792US9050367B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Jun 9, 2015·13 cites·5 claims
- 0891US8652489B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Feb 18, 2014·11 cites·8 claims
- 0990US9975929B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted May 22, 2018·6 cites·3 claims
- 1090US7829525B2Formulation for a protein pharmaceutical without added human serum albumin (HSA)MERZ PHARMA GMBH & CO KGAA·Filed 2004·Granted Nov 9, 2010·51 cites·22 claims
- 1188US10725025B2Methods for enhancing the specific uptake of botulinum neurotoxins into cellsMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted Jul 28, 2020·5 cites·25 claims
- 1288US7964199B1Therapeutic composition comprising a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2000·Granted Jun 21, 2011·35 cites·8 claims
- 1386US10406290B2Botulinum toxin prefilled plastic syringeMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Sep 10, 2019·6 cites·15 claims
- 1486US9511114B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Dec 6, 2016·5 cites·5 claims
- 1585US2026007829A1Botulinum toxin prefilled containerMERZ PHARMA GMBH & CO KGAA·Filed 2025·Application pending·0 cites
- 1683US10603353B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted Mar 31, 2020·2 cites·27 claims
- 1783US9095523B2High frequency application of botulinum toxin therapyMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Aug 4, 2015·7 cites·17 claims
- 1882US9572871B2High frequency application of botulinum toxin therapyMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Feb 21, 2017·4 cites·18 claims
- 1982US2026053987A1Method for dynamic filtration of a cross-linked hydrogelMERZ PHARMA GMBH & CO KGAA·Filed 2025·Application pending·0 cites
- 2081US10653754B2Highly pure neurotoxic component of a botulinum toxin and uses thereofMERZ PHARMA GMBH & CO KGAA·Filed 2018·Granted May 19, 2020·2 cites·15 claims
- 2181US10640578B2Modified hyaluronic acid, method for making same and uses thereofMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted May 5, 2020·1 cites·17 claims
- 2281US9937245B2Highly pure neurotoxic component of a botulinum toxin, process for preparing same, and uses thereofMERZ PHARMA GMBH & CO KGAA·Filed 2014·Granted Apr 10, 2018·7 cites·20 claims
- 2381US9314514B2Modified neurotoxins with poly-glycine and uses thereofMERZ PHARMA GMBH & CO KGAA·Filed 2012·Granted Apr 19, 2016·6 cites·12 claims
- 2480US11874273B2Means and methods for the determination of the biological activity of BoNT/E in cellsMERZ PHARMA GMBH & CO KGAA·Filed 2020·Granted Jan 16, 2024·1 cites·4 claims
- 2580US10781421B2Cellular test systems for the determination of the biological activities of neurotoxin polypeptidesMERZ PHARMA GMBH & CO KGAA·Filed 2018·Granted Sep 22, 2020·2 cites·13 claims
- 2680US10709772B2Use of botulinum neurotoxin in the treatment of sialorrheaMERZ PHARMA GMBH & CO KGAA·Filed 2018·Granted Jul 14, 2020·5 cites·20 claims
- 2780US10125350B2Cellular test systems for the determination of the biological activities of neurotoxin polypeptidesMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Nov 13, 2018·4 cites·12 claims
- 2880US9193771B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Nov 24, 2015·3 cites·3 claims
- 2980US7985753B2Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted Jul 26, 2011·6 cites·19 claims
- 3079US11219717B2Botulinum toxin prefilled plastic syringeMERZ PHARMA GMBH & CO KGAA·Filed 2019·Granted Jan 11, 2022·2 cites·18 claims
- 3179US10792344B2High frequency application of botulinum toxin therapyMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Oct 6, 2020·1 cites·14 claims
- 3279US9809809B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2012·Granted Nov 7, 2017·6 cites·17 claims
- 3379US8895713B2Clostridial neurotoxins with altered persistencyMERZ PHARMA GMBH & CO KGAA·Filed 2014·Granted Nov 25, 2014·3 cites·5 claims
- 3479US8003601B2Pegylated mutated clostridium botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted Aug 23, 2011·4 cites·28 claims
- 3578US6828462B2Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2002·Granted Dec 7, 2004·14 cites·9 claims
- 3677US12275782B2Means and methods for the determination of the biological activity of neurotoxin polypeptides in cellsMERZ PHARMA GMBH & CO KGAA·Filed 2024·Granted Apr 15, 2025·0 cites·11 claims
- 3777US11167090B2Botulinum toxin prefilled containerMERZ PHARMA GMBH & CO KGAA·Filed 2019·Granted Nov 9, 2021·0 cites·15 claims
- 3876US7927836B2Device and method for the production of biologically active compounds by fermentationMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted Apr 19, 2011·6 cites·28 claims
- 3975US11529398B2Use of botulinum neurotoxin in the treatment of sialorrheaMERZ PHARMA GMBH & CO KGAA·Filed 2020·Granted Dec 20, 2022·1 cites·22 claims
- 4075US11357821B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2019·Granted Jun 14, 2022·1 cites·23 claims
- 4175US10900955B2Means and methods for the determination of the biological activity of BoNT/E in cellsMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Jan 26, 2021·2 cites·11 claims
- 4275US10335512B2Dermal filler based on crosslinked hyaluronic acid and carboxymethyl cellulose lubricantMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Jul 2, 2019·3 cites·14 claims
- 4374US12434002B2Botulinum toxin prefilled containerMERZ PHARMA GMBH & CO KGAA·Filed 2021·Granted Oct 7, 2025·0 cites·15 claims
- 4474US2022305096A1High frequency application of botulinum toxin therapyMERZ PHARMA GMBH & CO KGAA·Filed 2022·Application pending·0 cites
- 4574US2022305095A1High frequency application of botulinum toxin therapyMERZ PHARMA GMBH &CO KGAA·Filed 2022·Application pending·0 cites
- 4673US12324903B2Botulinum toxin prefilled plastic syringeMERZ PHARMA GMBH & CO KGAA·Filed 2021·Granted Jun 10, 2025·0 cites·12 claims
- 4773US11324672B2Method for preparing hyaluronic acid dermal fillers, dermal fillers obtained thereby and their useMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted May 10, 2022·1 cites·9 claims
- 4872US12478663B2Use of botulinum neurotoxin in the treatment of sialorrheaMERZ PHARMA GMBH & CO KGAA·Filed 2022·Granted Nov 25, 2025·0 cites·12 claims
- 4971US9186396B2PEGylated mutated Clostridium botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2014·Granted Nov 17, 2015·1 cites·22 claims
- 5071US2025064708A1Use of botulinum toxin for reduction of skin pore size and sebum productionMERZ PHARMA GMBH & CO KGAA·Filed 2023·Application pending·0 cites
Showing the top 50 of 169 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MERZ PHARMA GMBH & CO KGAA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →